Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Elanco Animal Health Incorporated Common Stock
(NY:
ELAN
)
19.80
-0.13 (-0.65%)
Official Closing Price
Updated: 4:10 PM EDT, May 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elanco Animal Health Incorporated Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
3 Reasons to Sell ELAN and 1 Stock to Buy Instead
May 15, 2026
Since November 2025, Elanco has been in a holding pattern, floating around $21.39. The stock also fell short of the S&P 500’s 11.5% gain during that period. ...
Via
StockStory
Topics
Stocks
5 Insightful Analyst Questions From Elanco’s Q1 Earnings Call
May 13, 2026
Elanco’s first quarter results were met with a positive market reaction, as management pointed to broad-based revenue growth across its pet health and farm a...
Via
StockStory
Topics
Earnings
Elanco Animal Health Q1 Earnings Call Highlights
↗
May 10, 2026
Elanco Animal Health (NYSE:ELAN) raised its 2026 outlook after reporting stronger-than-expected first-quarter results, citing broad-based growth across pet health and farm animal businesses,...
Via
MarketBeat
Topics
Earnings
ELAN Q1 Deep Dive: Innovation Products and Margin Expansion Steer Strong Start
May 07, 2026
Animal health company Elanco (NYSE:ELAN) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 14.9% year on year to $1.37 bill...
Via
StockStory
Elanco Animal Health (NYSE:ELAN) Soars After Strong Q1 Beat, Raises Full-Year Outlook
↗
May 06, 2026
Via
Chartmill
Elanco Animal Health Inc (NYSE:ELAN) Reports Strong Q4 Earnings Beat and Confirms 2026 Guidance
↗
February 24, 2026
Via
Chartmill
Topics
Earnings
Elanco (ELAN) Q1 2026 Earnings Transcript
↗
May 06, 2026
Elanco (ELAN) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Economy
Elanco’s (NYSE:ELAN) Q1 CY2026 Sales Beat Estimates
May 06, 2026
Animal health company Elanco (NYSE:ELAN) announced better-than-expected revenue in Q1 CY2026, with sales up 14.9% year on year to $1.37 billion. The company ...
Via
StockStory
Topics
Earnings
Elanco (ELAN) Q1 Earnings: What To Expect
May 04, 2026
Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before the bell. Here’s what investors should know. Elanco beat analysts’ r...
Via
StockStory
Topics
Artificial Intelligence
Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks
April 22, 2026
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the pharmaceuticals stocks, including Elanco (NYSE:ELAN) and its peers. The pharmaceuti...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Mid-Cap Stocks Walking a Fine Line
April 13, 2026
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via
StockStory
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
April 06, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via
StockStory
Topics
Artificial Intelligence
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
March 27, 2026
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via
StockStory
Topics
Government
Stocks
1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds
March 23, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...
Via
StockStory
Topics
Artificial Intelligence
Elanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?
March 12, 2026
Elanco’s 26.6% return over the past six months has outpaced the S&P 500 by 23.6%, and its stock price has climbed to $23.47 per share. This was partly thanks...
Via
StockStory
Topics
Stocks
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know
March 06, 2026
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Via
StockStory
Topics
Economy
Government
World Trade
USDA Deploys $100 Million 'Screwworm Challenge' to Safeguard U.S. Livestock and Dairy Frontier
March 02, 2026
The United States Department of Agriculture (USDA) has officially greenlit a massive $100 million initiative dubbed the "Screwworm Challenge," aimed at neutralizing a resurgent biological threat that...
Via
MarketMinute
Topics
Economy
Why Is Elanco (ELAN) Stock Soaring Today
February 24, 2026
Shares of animal health company Elanco (NYSE:ELAN) jumped 8.2% in the morning session after the company reported fourth-quarter results that surpassed Wall Street's expectations, with investors...
Via
StockStory
Topics
Artificial Intelligence
Elanco (ELAN) Q4 2025 Earnings Call Transcript
↗
February 24, 2026
Elanco (ELAN) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Economy
Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales
February 24, 2026
Animal health company Elanco (NYSE:ELAN) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 12.2% year on year to $1.14 billion. Guidance for next quarter’s revenue was...
Via
StockStory
What To Expect From Elanco’s (ELAN) Q4 Earnings
February 22, 2026
Animal health company Elanco (NYSE:ELAN) will be reporting earnings this Tuesday before market open. Here’s what you need to know.
Via
StockStory
Why a $104 Million Allocation to Eagle Materials Stock Could Signal Confidence in Construction’s Next Cycle
↗
February 14, 2026
This U.S. supplier serves construction and packaging markets with a diverse mix of cement, aggregates, wallboard, and paperboard.
Via
The Motley Fool
Topics
Regulatory Compliance
Supply Chain
Why a $183 Million Bet on FTI Consulting Signals Upside Potential Amid a 16% One-Year Drop
↗
February 14, 2026
FTI Consulting provides business advisory services worldwide, specializing in transformation, risk mitigation, and dispute resolution.
Via
The Motley Fool
NICE Stock Down 38.5% as One Fund Dumps $32.75 Million. Here's What Investors Should Know
↗
February 14, 2026
This enterprise software provider delivers cloud-based AI solutions for customer engagement, compliance, and financial crime prevention.
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
February 12, 2026
Zoetis Inc. (NYSE: ZTS) stands today as the undisputed global leader in animal health, a position it has fortified since its historic decoupling from Pfizer over a decade ago. As of February 12, 2026,...
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm
February 11, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border
February 05, 2026
In a decisive move to protect the nation’s multi-billion dollar livestock industry, U.S. Secretary of Agriculture Brooke Rollins announced today, February 5, 2026, the launch of a $100 million "New...
Via
MarketMinute
Topics
Death
Economy
2 Profitable Stocks to Own for Decades and 1 Facing Headwinds
January 26, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via
StockStory
3 Mid-Cap Stocks with Open Questions
January 25, 2026
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...
Via
StockStory
3 Reasons to Avoid ELAN and 1 Stock to Buy Instead
January 06, 2026
The past six months have been a windfall for Elanco’s shareholders. The company’s stock price has jumped 64.6%, setting a new 52-week high of $23.81 per share. This was partly thanks to its solid...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today